Therapeutics and Clinical Risk Management
Volume 16, 2020 - Issue
Original Research
Cost-Effectiveness Analysis of Spending on Research and Development to Address the Needs for Innovative Therapeutic Products in Indonesia
Auliya A Suwantika1 Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia;2 Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia;3 Center for Health Technology Assessment, Universitas Padjadjaran, Bandung, IndonesiaCorrespondence[email protected]
https://orcid.org/0000-0001-8671-2065
https://orcid.org/0000-0001-8671-2065, Angga P Kautsar4 Department of Pharmaceutical and Pharmacy Technology, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia;5 Unit of Global Health, Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlandshttps://orcid.org/0000-0001-6868-5286
https://orcid.org/0000-0001-6868-5286, Neily Zakiyah1 Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia;2 Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesiahttps://orcid.org/0000-0002-9630-5567
https://orcid.org/0000-0002-9630-5567, Rizky Abdulah1 Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Bandung, Indonesia;2 Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesiahttps://orcid.org/0000-0002-8779-6421
https://orcid.org/0000-0002-8779-6421, & 